Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherANALGESIA AND DRUGS OF ABUSE

Delta Opioid Receptor Subtypes Activate Inositol-Signaling Pathways in the Production of Antinociception

Pilar Sánchez-Blázquez and Javier Garzón
Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 820-827;
Pilar Sánchez-Blázquez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Garzón
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

To analyze the selectivity of delta receptor subtypes to regulate different classes of G proteins, the expression of the α-subunits of Gi2, Gi3, Go1, Go2, Gq and G11 transducer proteins was reduced by administration of oligodeoxynucleotides (ODNs) complementary to sequences in their respective mRNAs. Mice receiving antisense ODNs to Gi2α, Gi3α, Go2α and G11α subunits showed an impaired antinociceptive response to all the delta agonists evaluated. An ODN to Go1α specifically blocked the antinociceptive effect of the agonist of delta-1 receptors, [d-Pen2,5]enkephalin (DPDPE), without altering the activity of [d-Ala2]deltorphin II or [d-Ser2]-Leu-enkephalin-Thr (DSLET). In mice treated with an ODN to Gqα, the effects of the agonists of delta-2-opioid receptors were reduced, but not those of DPDPE. Thus, Go1 proteins are selectively linked todelta-1-mediated analgesia, and Gq proteins are related to delta-2-evoked antinociception. After impairing the synthesis of Go1α subunits, DPDPE exhibited an antagonistic activity on the antinociception produced by [d-Ala2]deltorphin II. After treatment with ODNs complementary to sequences in Gqα or PLC-β1 mRNAs, the analgesic capacity of [d-Ala2]deltorphin II was diminished. However, the delta-2-agonist did not alter the antinociceptive activity of DPDPE. An ODN complementary to nucleotides 7 to 26 of the murine delta receptor reduced the analgesic potency of [d-Ala2]deltorphin II, but not that observed for DPDPE. In these mice, [d-Ala2]deltorphin II did not antagonize the effect of DPDPE. These results suggest the existence of different molecular forms of the delta opioid receptor, and the involvement of inositol-signaling pathways in the supraspinal antinociceptive effects of delta agonists.

Footnotes

  • Send reprint requests to: Dr. Pilar Sánchez-Blázquez, Instituto Cajal, CSIC, Avenida Doctor Arce 37, E-28002, Madrid, Spain.

  • ↵1 This research was supported by the Comisión Interministerial de Ciencia y Tecnologı́a (Grant SAF95-0003), CAM (Grant AE00363/95) and Fondo de Investigaciones Sanitarias (Grant 97/0506).

  • Abbreviations:
    delta-1 anddelta-2
    subtypes of the delta opioid receptor
    DPDPE
    [d-Pen2,5]enkephalin
    DSLET
    [d-Ser2]-Leu-enkephalin-Thr
    G proteins
    GTP-binding proteins
    PLC
    phophoinositide-specific phospholipase C
    ODN
    antisense oligodeoxynucleotide
    RD
    random oligodeoxynucleotide
    i.c.v.
    intracerebroventricular
    PAG
    periaqueductal gray matter
    MPE
    maximum possible effect
    • Received September 23, 1997.
    • Accepted January 29, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 285, Issue 2
1 May 1998
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Delta Opioid Receptor Subtypes Activate Inositol-Signaling Pathways in the Production of Antinociception
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherANALGESIA AND DRUGS OF ABUSE

Delta Opioid Receptor Subtypes Activate Inositol-Signaling Pathways in the Production of Antinociception

Pilar Sánchez-Blázquez and Javier Garzón
Journal of Pharmacology and Experimental Therapeutics May 1, 1998, 285 (2) 820-827;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherANALGESIA AND DRUGS OF ABUSE

Delta Opioid Receptor Subtypes Activate Inositol-Signaling Pathways in the Production of Antinociception

Pilar Sánchez-Blázquez and Javier Garzón
Journal of Pharmacology and Experimental Therapeutics May 1, 1998, 285 (2) 820-827;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Effect of COX-1 and COX-2 Inhibition on Induction and Maintenance of Carrageenan-Evoked Thermal Hyperalgesia in Rats
  • Delta Opioid Receptor Enhancement ofMu Opioid Receptor-Induced Antinociception in Spinal Cord
  • Pharmacodynamics of a Monoclonal Antiphencyclidine Fab with Broad Selectivity for Phencyclidine-Like Drugs1
Show more ANALGESIA AND DRUGS OF ABUSE

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics